NR4A1 and breast cancer: Similarly, in the medical literature, most publications report a very strong correlation between FOXA1 positivity in breast cancers and the expression of the hormone receptors ER and PR [56, 57, 69, 72], confirmed by two meta-analyses [70, 73], AR [74], and the luminal-A phenotype [56, 57, 69, 72].